Table I.
Comparison of the clinical features of 77 patients with definite and probable AIH diagnoses according to the revised scoring system.
| Parameters | Definite AIH (score >15) (n=39) | Probable AIH (score 10–15) (n=38) | χ2 | P-value |
|---|---|---|---|---|
| Female | 34 | 33 | 0.002 | 0.965 |
| Concurrent autoimmune diseases | 23 | 21 | 0.108 | 0.820 |
| ALP:AST ratio | 0.004 | 0.998 | ||
| 1.5–3 | 5 | 5 | ||
| <1.5 | 30 | 29 | ||
| IgG | 4.293 | 0.117 | ||
| Normal | 3 | 8 | ||
| Abnormal | 36 | 30 | ||
| ANA or SMA | 10.085 | 0.010 | ||
| ≥1:80>x≥1:40 | 13 | 6 | ||
| ≥1:80 | 18 | 11 | ||
| Anti-SLA/LP or pANCA | 7 | 7 | 0.003 | 1.000 |
| Liver histology | 22 | 11 | 5.927 | 0.021 |
AIH, autoimmune hepatitis; ALP, alkaline phosphatase; AST, aspartate aminotransferase; IgG, immunoglobulin G; ANA, antinuclear antibody; SLA/LP, soluble liver antigen/liver-pancreas antigen; pANCA, perinuclear antineutrophil cytoplasmic antibody.